F 0693
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure that feeding tubes are not used unless there is a medical reason and the resident agrees; and
provide appropriate care for a resident with a feeding tube.
Based on observation, interview, and record review, the facility failed to maintain the head of bed at thirty
degrees while a resident's tube feeding was infusing. This applies to 1 of 4 residents R1 reviewed for their
tube feeding in a sample of 8.Findings include:On 10/15/25 at 10:33 AM, R1 was observed during care
provision by V9 and V10, CNAs (Certified Nursing Assistants). While R1 was in bed, the head of the bed
was in a flat position. The tube feeding of Nepro 1.8 Cal was infusing at 40 ML (Milliliters) per hour by a
feeding pump. V10 CNA stated residents receiving their tube feedings only needed to have the head of bed
elevated if the resident is being rolled side to side, otherwise it is ok for the resident to be flat with the tube
feeding infusing.V9 CNA stated there was no problem with R1's head of bed being flat while her tube
feeding was infusing if she was not being turned side to side as it may cause R1 to become sick.On
10/15/25 at 5:15 PM, V2, DON (Director of Nursing), stated the head of bed should be elevated when the
tube feeding is infusing so that the resident does not vomit or aspirate.R1's physician orders tube feeding
states may stop feeding during routine care, ADL's (Activities of Daily Living), bathing, notify nurse to
restart. Every shift elevates head of bed 30 -45 degrees while feeding.The facility policy Tube Feeding,
dated 11/2024, states the head of bed will be 30-45 degrees unless ordered differently.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
145372
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145372
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/17/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Pearl of Joliet, The
306 North Larkin Avenue
Joliet, IL 60435
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review, the facility failed to administer the ordered initial dose of an
antibiotic. This applies to 1 of 4 residents R1 reviewed for antibiotic administration in a sample of 8.Findings
include:V5, NP (Nurse Practitioner) progress note on 9/12/25 documents the plan for to treat a UTI (Urinary
Tract Infection) with Levofloxacin IV (Intravenously). Levofloxacin 750 MG (Milligrams) to start on 9/13/25
and end 9/14/25. Levofloxacin 500 MG administered every 48 hours for 10 days starting 0 9/15/25 and
ending on 9/25/25. Meropenem 500 MG intravenously daily for 7 days starting on 9/9/25.R1's MAR
(Medication Administration Record) shows a missed administration of Meropenem 500 MG on 9/14/25 at
9am. There is no documentation for the administration of Levofloxacin 750 MG on R1's MAR on 9/13/25 or
9/14/25. V4, LPN (Licensed Practical Nurse) progress, note dated 9/14/25 at 3:25 AM, states call to
pharmacy related to Levofloxacin would be delivered early in AM. A nursing progress note, dated 9/14/25 at
6:42 PM, states Levofloxacin 750 MG was not available and would be delivered that night. Calls placed to
interview V5, NP, and V4, LPN, were unsuccessful.V2, DON (Director of Nursing), stated there was no
documentation showing R1 received the Meropenem 500 MG on 9/14/25. V2 stated she did not receive any
authorization requests from pharmacy for R1 to receive the one-time dose of Levofloxacin 750 MG. V2,
DON, stated there was no documentation showing R1 received the one-time dose of Levofloxacin 750
MG.The facility policy Medication Ordering and Receiving from Pharmacy, dated November 2021, states a
licensed nurse promptly reports discrepancies and omissions to the issuing pharmacy and the charge
nurse / supervisor.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145372
If continuation sheet
Page 2 of 2